Page last updated: 2024-09-03

mk 0663 and Coronary Artery Disease

mk 0663 has been researched along with Coronary Artery Disease in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	1 (100.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Becker, V; Bulut, D; Mügge, A	1

Other Studies

1 other study(ies) available for mk 0663 and Coronary Artery Disease

Article	Year
Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease. Canadian journal of physiology and pharmacology, 2011, Volume: 89, Issue:4 Topics: Aspirin; Blood Platelets; Cell-Derived Microparticles; Coronary Artery Disease; Cyclooxygenase 2 Inhibitors; Endothelial Cells; Endothelium, Vascular; Etoricoxib; Humans; Male; Middle Aged; Pyridines; Stem Cells; Sulfones; Vasodilation	2011

Article

Year

Acetylsalicylate reduces endothelial and platelet-derived microparticles in patients with coronary artery disease.

Canadian journal of physiology and pharmacology, 2011, Volume: 89, Issue:4

Topics: Aspirin; Blood Platelets; Cell-Derived Microparticles; Coronary Artery Disease; Cyclooxygenase 2 Inhibitors; Endothelial Cells; Endothelium, Vascular; Etoricoxib; Humans; Male; Middle Aged; Pyridines; Stem Cells; Sulfones; Vasodilation

2011